Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00267436 |
Recruitment Status
:
Completed
First Posted
: December 21, 2005
Last Update Posted
: April 13, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Prevention STD Prevention | Behavioral: Community PROMISE | Phase 1 Phase 2 |
During the ADAPT project both sites will adapt the original Community Promise intervention to specifically address the HIV prevention needs of sero-positive, African American men who have sex with men (HIV+ AAMSM) in either Boston, MA or Minneapolis/St. Paul (MSP), MN. The adapted intervention will be referred to as Community PROMISE, Positives Leading and Utilizing Strategies (CP PLUS).
In the first two months of the ADAPT project, the Boston and MSP sites will conduct formative evaluation activities (i.e., a comprehensive literature review, focus groups, and individual interviews) to assess the needs of the target population and organizational capacities to serve them. Results will be used to inform the adaptation of the original intervention to ensure that CP PLUS meet the expressed needs of the target population.
Process data will also be collected from various sources throughout the life of the project. Process data will be collected through staff meetings, interviews with staff, focus groups with peer advocates, and an expert panel consultation. Process data will be extremely useful for ensuring program objectives are met, improving CP PLUS, and providing information for providers in other locales who may be interested in adapting this intervention to serve this target population.
The Boston and MSP sites will also conduct outcome monitoring through collection of data concerning risk behaviors pre- and post-intervention implementation (follow-up at 6-8 months post and 11-13 months post [Boston only]) to determine if the adapted intervention has met its outcome objectives. Outcome monitoring will also be conducted for the "parent" intervention at both sites for HIV- or unknown status men who have sex with men.
In addition to the project activities, the organization will be examining the utility of the CDC draft guidance. The Boston and MSP sites are two of five case studies throughout the United States that will detail the challenges, successes and lessons learned from adapting an intervention packaged by CDC's Replicating Effective Programs (REP) and disseminated by Diffusing Effective Behavioral Interventions (DEBI) to a specific population. These findings will help other community-based organizations and Health Departments effectively adapt and tailor group, individual and community-level interventions.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 574 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE Positives Leading and Utilizing Strategies (ADAPT CP PLUS) |
Study Start Date : | July 2006 |
Actual Primary Completion Date : | February 2007 |
Actual Study Completion Date : | February 2007 |

-
Behavioral: Community PROMISE
- Sexual activities with main and casual partners in past 30 days to 6 months (i.e., unprotected insertive and receptive anal/vaginal sex and protected insertive and receptive anal/vaginal sex) [ Time Frame: 7/2006-2/2007 ]
- Behavioral intentions and attitudes for condom use; disclosure of HIV status; self reported STD diagnosis; medication adherence; links to care. [ Time Frame: 7/2006-2/2007 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
HIV+ cohort
- Self-reports as HIV+ (for CP PLUS cohort)
- Self-report that they had sex with men in the past 3 years (MSP) or 1 year (Boston)
- Self-reports as a resident of the identified geographic areas.
- Identifies as African American
- 18 years of age, or older.
HIV- cohort
- HIV- or unknown status only, has engaged in risky sexual contact (defined as those who self-report engaging in unprotected anal or vaginal intercourse within the past year)
- Self-report that they had sex with men in the past 3 years (MSP) or 1 year (Boston)
- Identifies as African American (MSP); No racial/ethnic criteria however AA will be over-sampled and will be at least 20% of sample
- 18 years of age, or older.
- Self-reports as a resident of the identified geographic areas.
- Engage in risky sex (defined as individuals who self-report engaging in unprotected anal or vaginal intercourse within the past year.
Exclusion Criteria:
- Inability to complete informed consent process due to (a) substantial cognitive impairment. (b) non-English speaking; (c) under the influence of drugs or alcohol
- Under 18 years of age
- Plans to relocate within 12 months after baseline interview
- Anyone who does not meet inclusion criteria

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00267436
United States, Massachusetts | |
AIDS Action Committee | |
Boston, Massachusetts, United States, 02118 | |
United States, Minnesota | |
Minneapolis Urban League | |
Minneapolis, Minnesota, United States, 55455 |
Study Director: | Jennifer S Galbraith | Centers for Disease Control and Prevention |
Responsible Party: | Jennifer Galbraith/ Behavioral Scientist, Centers for Disease Control and Prevention |
ClinicalTrials.gov Identifier: | NCT00267436 History of Changes |
Other Study ID Numbers: |
CDC-NCHSTP-U65/CCU523908 U65/CCU523908-01 |
First Posted: | December 21, 2005 Key Record Dates |
Last Update Posted: | April 13, 2012 |
Last Verified: | April 2012 |
Keywords provided by Centers for Disease Control and Prevention:
adaptation HIV prevention HIV positive evidence based interventions HIV Seronegativity |